Clinical Laboratory Experience With Prenatal cfDNA Screening in Triplet Pregnancies
The data from this study support the notion that cfDNA screening in triplet pregnancies is a reasonable approach given the lack of alternative screening options for these patients and that the performance likely approaches that of twin pregnancies, albeit with a higher no-call rate.
Authors
- Hany Magharyous
- Brittany Dyr (ORCID: https://orcid.org/0000-0002-6304-4276)
- Phillip Michael Cacheris (ORCID: https://orcid.org/0000-0002-3491-0841)
- Erica Soster (ORCID: https://orcid.org/0000-0003-4464-8872)
- Samantha Caldwell (ORCID: https://orcid.org/0000-0001-9210-4752)
- Shannon Moore (ORCID: https://orcid.org/0000-0002-4986-1659)
- Eyad Almasri
- Juan‐Sebastian Saldivar
Institutions
- LabCorp (United States) (US)
- Wake Forest University (US)
Publication Details
- Journal
- Prenatal Diagnosis
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1002/pd.6812
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00